Key Bone Repair Patent Granted in the United States
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Mesoblast
- TGA Approval To Commercially Manufacture Stem Cell Products
- Response to an ASX Price Query
- Positive Results From Phase 2 Lumbar Fusion Trial
- Phase 3 Meeting Set With FDA On Bone Marrow Regeneration
- On Track for Phase 3 BMT Trial After Positive FDA Meeting
Later from Mesoblast
- MSB partner jcr files for product approval
- Mesoblast Cells Show Disease Modifying Effects on Knee OA
- Mesoblast Provides Q3 Financial Results and Corporate Update
- Mesoblast Receives $6.2m From Aus Govt For R&D
- Suspension from Official Quotation
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast